rEK (Recombinant Enterokinase)
Mostly the existing Enterokinase face challenges of low purity, endotoxins, and batch to batch variations. To overcome these challenges and provide the best to the biotechnological market, we have come up with recombinant Enterokinase (rEK) manufactured using the most advanced Pichia Pastoris Protein Expression System.
Enterokinase is a protease that acts in a precise manner by hydrolyzing the bonds between specific residues or a specific sequence of amino acid residues within a protein or peptide. Our recombinant Enterokinase (rEK) recognizes the sequence Asp-Asp-Asp-Asp-Lys and cleaves the peptide bond after the lysine residue in a targeted manner. The highly specific cleavage activity of rEK increases the productivity of the experiment and reduces any false-positive results.
Lazuline offers a recombinant version of Enterokinase which is manufactured using a complex yeast expression system. This makes the resultant protein highly pure and animal-origin free. It is the perfect alternative to existing proteases due to high efficacy and free of any contaminants.
Batch to Batch Consistency
Delivering highly consistent product in the market is the need of the hour. Lazuline value this and with the help of highly experienced scientists have devised own innovative techniques to avoid batch to batch inconsistency across the products. Our recombinant Enterokinase shows consistency across all the batches and is tested resourcefully to ensure that the product meets all necessary specifications.
Lazuline’s recombinant Enterokinase is manufactured in a highly sterile environment using established scientific procedures. To provide high-quality biotherapeutics in the market, the target protein/ peptide is purified using high-grade chromatography techniques.